Parvalbumin: Targeting calcium handling in cardiac diastolic dysfunction

General Physiology and Biophysics

Volumn 28, Issue , 2009, Pages

  Wang, Wang ^a   Martindale, Joshua ^a   Metzger, Joseph M ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Calcium handling; Diastolic heart failure; Parvalbumin

Indexed keywords

CALCIUM ION; PARVALBUMIN;

CALCIUM BINDING; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL CULTURE; CELL ENERGY; CONFERENCE PAPER; DIASTOLIC DYSFUNCTION; DIASTOLIC HEART FAILURE; DRUG MECHANISM; GENE TRANSFER; HEART MUSCLE CELL; HEART MUSCLE RELAXATION; HEART PERFORMANCE; HUMAN; IN VIVO STUDY; NONHUMAN;

AMINO ACID MOTIFS; ANIMALS; CALCIUM; CYTOSOL; DIASTOLE; GENE TRANSFER TECHNIQUES; HEART FAILURE; HUMANS; MUSCLE, SKELETAL; MYOCARDIUM; MYOCYTES, CARDIAC; PARVALBUMINS;

EID: 77149169379     PISSN: 02315882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (36)

1. Arai M., Matsui H., Periasamy M. (1994): Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure. Circ. Res. 74, 555-564
2. Chinnaiyan K. M., Alexander D., Maddens M., McCullough P. A. (2007): Curriculum in cardiology: integrated diagnosis and management of diastolic heart failure. Am. Heart J. 153, 189-200
3. Coutu P., Bennett C. N., Favre E. G., Day S. M., Metzger J. M. (2004): Parvalbumin corrects slowed relaxation in adult cardiac myocytes expressing hypertrophic cardiomy-opathy-linked a-tropomyosin mutations. Circ. Res. 94, 1235-1241
4. Coutu P., Hirsch J. C., Szatkowski M. L., Metzger J. M. (2003): Targeting diastolic dysfunction by genetic engineering of calcium handling proteins. Trends Cardiovasc. Med. 13, 63-67
5. Coutu P., Metzger J. M. (2002): Optimal range for parvalbumin as relaxing agent in adult cardiac myocytes: gene transfer and mathematical modeling. Biophys. J. 82, 2565-2579
6. Coutu P., Metzger J. M. (2005): Genetic manipulation of calcium-handling proteins in cardiac myocytes. II. Mathematical modeling studies. Am. J. Physiol. Heart Circ. Physiol. 288, H613-631
7. del Monte F., Hajjar R. J. (2003): Targeting calcium cycling proteins in heart failure through gene transfer. J. Physiol. 546, 49-61
8. del Monte F., Harding S. E., Schmidt U., Matsui T., Kang Z. B., Dec G. W., Gwathmey J. K., Rosenzweig A., Hajjar R. J. (1999): Restoration of contractile function in isolated cardio-myocytes from failing human hearts by gene transfer of SERCA2a. Circulation 100, 2308-2311
9. Hirsch J. C., Borton A. R., Albayya F. P., Russell M. W., Ohye R. G., Metzger J. M. (2004): Comparative analysis of parvalbumin and SERCA2a cardiac myocyte gene transfer in a large animal model of diastolic dysfunction. Am. J. Physiol. Heart Circ. Physiol. 286, H2314-2321
10. Hoshijima M. (2005): Gene therapy targeted at calcium handling as an approach to the treatment of heart failure. Pharmacol. Ther. 105, 211-228
11. Houser S. R., Piacentino V. 3rd, Mattiello J., Weisser J., Gaughan J. P. (2000): Functional properties of failing human ventricular myocytes. Trends Cardiovasc. Med. 10, 101-107
12. Huq F., Lebeche D., Iyer V., Liao R., Hajjar R. J. (2004): Gene transfer of parvalbumin improves diastolic dysfunction in senescent myocytes. Circulation 109, 2780-2785
13. Kitzman D. W., Gardin J. M., Gottdiener J. S., Arnold A., Boineau R., Aurigemma G., Marino E. K., Lyles M., Cushman M., Enright P. L. (2001): Importance of heart failure with preserved systolic function in patients > or = 65 years of age. CHS Research Group. Cardiovascular Health Study. Am. J. Cardiol. 87, 413-419
14. Michele D. E., Szatkowski M. L., Albayya F. P., Metzger J. M. (2004): Parvalbumin gene delivery improves diastolic function in the aged myocardium in vivo. Mol. Ther. 10, 399-403
15. Minamisawa S., Hoshijima M., Chu G., Ward C. A., Frank K., Gu Y., Martone M. E., Wang Y., Ross J. Jr., Kranias E. G., Giles W. R., Chien K. R. (1999): Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy. Cell 99, 313-322
16. Minamisawa, S., Sato Y., Cho M. C. (2004): Calcium cycling proteins in heart failure, cardiomyopathy and arrhythmias. Exp. Mol. Med. 36, 193-203
17. Molkentin J. D. (2005): Locating heart failure. Nat. Med. 11, 1284-1285
18. Most P., Pleger S. T., Volkers M., Heidt B., Boerries M., Weichenhan D., Loffler E., Janssen P. M., Eckhart A. D., Martini J., Williams M. L., Katus H. A., Remppis A., Koch W. J. (2004): Cardiac adenoviral S100A1 gene delivery rescues failing myocardium. J. Clin. Invest. 114, 1550-1563
19. Muntener M., Kaser L., Weber J., Berchtold M. W. (1995): Increase of skeletal muscle relaxation speed by direct injection of parvalbumin cDNA. Proc. Natl. Acad. Sci. U.S.A. 92, 6504-6508
20. Neubauer S. (2007): The failing heart - an engine out of fuel. N. Engl. J. Med. 356, 1140-1151
21. Owan T. E., Redfield M. M. (2005): Epidemiology of diastolic heart failure. Prog. Cardiovasc. Dis. 47, 320-332
22. 2+-binding proteins parvalbumin and oncomodulin and their genes: new structural and functional findings. Biochim. Biophys. Acta 1306, 39-54
23. 2+ content in isolated failing and nonfailing human myocardium. Circ. Res. 85, 38-46
24. Rodenbaugh D. W., Wang W., Davis J., Edwards T., Potter J. D., Metzger J. M. (2007): Parvalbumin isoforms differentially accelerate cardiac myocyte relaxation kinetics in an animal model of diastolic dysfunction. Am. J. Physiol. Heart Circ. Physiol. 293, H1705-1713
25. Sakata S., Lebeche D., Sakata N., Sakata Y., Chemaly E. R., Liang L. F., Tsuji T., Takewa Y., del Monte F., Peluso R., Zsebo K., Jeong D., Park W. J., Kawase Y., Hajjar R. J. (2007): Restoration of mechanical and energetic function in failing aortic-banded rat hearts by gene transfer of calcium cycling proteins. J. Mol. Cell. Cardiol. 42, 852-861
26. 2+ exchanger. Circ. Res. 87, 581-587
27. Schmidt U., Zhu X., Lebeche D., Huq E., Guerrero J. L., Hajjar R. J. (2005): In vivo gene transfer of parvalbumin improves diastolic function in aged rat hearts. Cardiovasc. Res. 66, 318-323
28. Schwaller B., Dick J., Dhoot G., Carroll S., Vrbova G., Nicotera P., Pette D., Wyss A., Bluethmann H., Hunziker W., Celio M. R. (1999): Prolonged contraction-relaxation cycle of fast-twitch muscles in parvalbumin knockout mice. Am. J. Physiol. 276, C395-403
29. Seidler T., Miller S. L., Loughrey C. M., Kania A., Burow A., Ket-tlewell S., Teucher N., Wagner S., Kogler H., Meyers M. B., Hasenfuss G., Smith G. L. (2003): Effects of adenovirus-mediated sorcin overexpression on excitation-contraction coupling in isolated rabbit cardiomyocytes. Circ. Res. 93, 132-139
30. Suarez J., Belke D. D., Gloss B., Dieterle T., McDonough P. M., Kim Y. K., Brunton L. L., Dillmann W. H. (2004): In vivo adenoviral transfer of sorcin reverses cardiac contractile abnormalities of diabetic cardiomyopathy. Am. J. Physiol. Heart Circ. Physiol. 286, H68-75
31. Szatkowski M. L., Westfall M. V., Gomez C., A., Wahr P. A., Michele D. E., DelloRusso C., Turner I. I., Hong K. E., Albayya F. P., Metzger J. M. (2001): In vivo acceleration of heart relaxation performance by parvalbumin gene delivery. J. Clin. Invest. 107, 191-198
32. 2+ exchanger. J. Physiol. 512, 651-667
33. Wahr P.A., Michele D. E., Metzger J. M. (1999): Parvalbumin gene transfer corrects diastolic dysfunction in diseased cardiac myocytes. Proc. Natl. Acad. Sci. U.S.A. 96, 11982-11985
34. Wang W., Metzger J. M. (2008): Parvalbumin isoforms for enhancing cardiac diastolic function. Cell Biochem. Biophys. 51, 1-8
35. Wehrens X. H., Lehnart S. E., Marks A. R. (2005): Intracellular calcium release and cardiac disease. Annu. Rev. Physiol. 67, 69-98
36. Zile M. R., Brutsaert D. L. (2002): New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment. Circulation 105, 1503-1508